Jean E. Bemis
Catabasis Pharmaceuticals (United States) · 18 works · 2,741 citations · h-index 13
Top works
- Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes
- A protein deacetylase SIRT1 is a negative regulator of metalloproteinase‐9
- Crystal Structures of Human SIRT3 Displaying Substrate-induced Conformational Changes
- Biochemical characterization, localization, and tissue distribution of the longer form of mouse SIRT3
- Discovery of Imidazo[1,2- b ]thiazole Derivatives as Novel SIRT1 Activators
- Discovery of 4-amino-5,6-biaryl-furo[2,3-d]pyrimidines as inhibitors of Lck: Development of an expedient and divergent synthetic route and preliminary SAR
- Discovery of Aminoquinazolines as Potent, Orally Bioavailable Inhibitors of Lck: Synthesis, SAR, and in Vivo Anti-Inflammatory Activity
- Discovery of oxazolo[4,5-b]pyridines and related heterocyclic analogs as novel SIRT1 activators
- Discovery of novel 2,3-diarylfuro[2,3-b]pyridin-4-amines as potent and selective inhibitors of Lck: Synthesis, SAR, and pharmacokinetic properties
- Structure-Guided Design of Aminopyrimidine Amides as Potent, Selective Inhibitors of Lymphocyte Specific Kinase: Synthesis, Structure–Activity Relationships, and Inhibition of in Vivo T Cell Activation
- Structure–activity relationships of indole cytosolic phospholipase A 2 α inhibitors: substrate mimetics
- The Identification of the SIRT1 Activator SRT2104 as a Clinical Candidate
- Synthesis and Characterization of Fatty Acid Conjugates of Niacin and Salicylic Acid
- Erratum to “Discovery of novel 2,3-diarylfuro[2,3-b]pyridin-4-amines as potent and selective inhibitors of Lck: Synthesis, SAR, and pharmacokinetic properties” [Bioorg. Med. Chem. Lett. 17 (2007) 2299–2304]
- Erratum to “Discovery of 4-amino-5,6-biaryl-furo[2,3-d]pyrimidines as inhibitors of Lck: Development of an expedient and divergent synthetic route and preliminary SAR” [Bioorg. Med. Chem. Lett. 17 (2007) 2305–2309]
- Crystal Structure of Human SIRT3
- Crystal Structure of Human SIRT3 with ADPR bound to the AceCS2 peptide containing a thioacetyl lysine
- Crystal Structure of human SIRT3 with acetyl-lysine AceCS2 peptide